Article Text

Download PDFPDF
Rapid-onset febrile dermatosis
  1. M Décisier1,
  2. V Duhalde1,
  3. P Faure3,
  4. A Ammoury4,
  5. M Gony1,
  6. J Moreau5,
  7. J L Montastruc1,2,
  8. H Bagheri1,2
  1. 1
    Service de Pharmacologie Clinique, Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d’Information sur le Médicament, Centre Hospitalier Universitaire de Toulouse, France
  2. 2
    Laboratoire de Pharmacologie Médicale et Clinique, Unité de Pharmacoépidémiologie, EA 3696, Université de Toulouse, Faculté de Médecine, Toulouse, France
  3. 3
    Service de Gastroentérologie, Clinique Saint Jean du Languedoc, Toulouse, France
  4. 4
    Service de Dermatologie, Hôpital Purpan, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
  5. 5
    Service de Gastroentérologie et Nutrition, Hôpital Rangueil, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
  1. Dr H Bagheri, Faculté de Médecine, 37 allées Jules-Guesde, 31000 Toulouse, France; bagheri{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


A 49-year-old male patient with distal ulcerative colitis diagnosed in 2004 was treated with mesalazine. He was hospitalised in May 2005 with a serious flare up of his colitis (C-reactive protein (CRP) = 330 mg/l, 20 …

View Full Text


  • Robin Spiller, editor

  • Competing interests: None.

  • Patient consent: Obtained.

Linked Articles

  • Editor's quiz: GI snapshot
    BMJ Publishing Group Ltd and British Society of Gastroenterology